The FDA on Tuesday approved a new medication for people in the early stages of Alzheimer’s disease. Dr. Jon LaPook explains what the drug is meant to do and explores its limitations.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
